Cleared Traditional

K061605 - NEMIO XG, SAA-580A

K061605 is an FDA 510(k) clearance for NEMIO XG, manufactured by Toshiba America Medical Systems, In.C. The device is a Class 2 Radiology device with product code IYN cleared through the Traditional 510(k) pathway after a 13-day FDA review.

K061605 · Toshiba America Medical Systems, In.C · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2006
Decision
13d
Days
Class 2
Risk

K061605 is an FDA 510(k) clearance for the NEMIO XG, SAA-580A. Classified as System, Imaging, Pulsed Doppler, Ultrasonic within the IYN classification (a category covering pulsed Doppler and ultrasound imaging systems), Class II - Special Controls.

Submitted by Toshiba America Medical Systems, In.C (Tustin, US). The FDA issued a Cleared decision on June 22, 2006 after a review of 13 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1550 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Toshiba America Medical Systems, In.C devices

FDA 510(k) Submission Details - K061605

510(k) Number K061605 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 09, 2006
Decision Date June 22, 2006
Days to Decision 13 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
94d faster than avg
Panel avg: 107d · This submission: 13d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

IYN Device Classification - Class 2, Special Controls

Product Code IYN System, Imaging, Pulsed Doppler, Ultrasonic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - IYN System, Imaging, Pulsed Doppler, Ultrasonic

All 1099
Devices cleared under the same product code (IYN) and FDA review panel - the closest regulatory comparables to K061605.
ACUSON X300 DIAGNOSTIC ULTRASOUND SYSTEM
K061946 · Siemens Medical Solutions USA, Inc. · Jul 2006
GE VIVID - I
K061525 · General Electric Co. · Jul 2006
CTS-5500/CTS-6600 ULTRASONIC PULSED ECHO IMAGING SYSTEM
K061488 · Shantou Institute of Ultrasonic Instruments (Siui · Jun 2006
SIGMA 5000 SERIES, IMAGIC
K061437 · Kontron Medical Systems Sas · Jun 2006
GE LOGIQ 9, MODELS 2188900, 2375600, 2404587 AND 5150000
K061129 · General Electric Co. · Jun 2006
MYLAB30, 50, 70 AND 90 SYSTEMS ADDITION OF 3D/4D, MODELS 7300, 7350, 6150, 6100
K060827 · Esaote, S.P.A. · May 2006